Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Frontiers in Immunology

Immunology

Casey E. Gelber¹  Kristen J. Steenbergen¹  Johannes B. Goll¹  Travis L. Jensen¹  Tyler Grimes¹  Evan J. Anderson²  Azra Blazevic³  Daniel F. Hoft⁴  Hasse Walum⁵  Steven E. Bosinger⁶  Gregory K. Tharp⁷  Nirav B. Patel⁷  Muktha S. Natrajan⁸  Nadine G. Rouphael⁹  Mark J. Mulligan^1,10  Richard D. Head^1,11  Patrick Sanz^1,12 

[1] Department of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United States;Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States;Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States;Division of Infectious Diseases, Allergy, and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States;Division of Infectious Diseases, Allergy, and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States;Department of Molecular Microbiology & Immunology, Saint Louis University, St. Louis, MO, United States;Division of Microbiology & Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States;Division of Microbiology & Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States;Department of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, United States;Emory NPRC Genomics Core, Emory National Primate Research Center, Emory University, Atlanta, GA, United States;Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States;Emory NPRC Genomics Core, Emory National Primate Research Center, Emory University, Atlanta, GA, United States;Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States;Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States;Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States;Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States;Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States;Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United States;Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States;Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States;New York University Vaccine Center, New York, NY, United States;McDonnell Genome Institute, Washington University, St. Louis, MO, United States;Office of Biodefense, Research Resources and Translational Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States;

关键词: RNA-Seq;    statistical power;    ERCC;    tularemia vaccine (DVC-LVS);    gene filtering;    sequencing depth;    read length;    reproducibility;   

DOI  :  10.3389/fimmu.2023.1163550

 received in 2023-02-10, accepted in 2023-02-13,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Goll, Bosinger, Jensen, Walum, Grimes, Tharp, Natrajan, Blazevic, Head, Gelber, Steenbergen, Patel, Sanz, Rouphael, Anderson, Mulligan and Hoft